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Review
Total joint replacement in sub-Saharan
Africa: a systematic review
Peter SE Davies1 , Simon M Graham2,3, Sithombo Maqungo4
and William J Harrison5
Abstract
Outcomes of arthroplasty in sub-Saharan Africa are not widely reported. To our knowledge, this systematic review is the
first to explore this topic. Scopus, EMBASE, Medline and PubMed databases were searched, utilising MeSH headings and
Boolean search strategies. All papers from South Africa were excluded. Twelve papers reporting 606 total hip replace-
ments (THRs) and 763 total knee replacements (TKRs) were included. Avascular necrosis was the most common
indication for THR, whereas osteoarthritis was the main indication for TKR. HIV prevalence of up to 33% was seen.
Improvements were seen in patient-reported outcome measures in both THR and TKR. The dislocation rate in THR was
1.6%. The deep infection rate was 1.6% for TKRs and 0.5% for THRs. Positive results were reported, with comparable
complications to high-income countries. However, there is likely to be significant reporting bias and the introduction of
mandatory registries would enable more accurate monitoring across the region.
Keywords
Africa, sub-Saharan, registry, total hip replacement, THR, total knee replacement, TKR
Introduction
There are many patients in sub-Saharan Africa (SSA)
suﬀering from conditions that may beneﬁt from total
joint replacement (TJR). However, these countries com-
monly do not have adequate resources to oﬀer this ser-
vice to all eligible patients.1 TJR of the hip and knee is
performed frequently in high-income countries and evi-
dence supports that these procedures are cost-eﬀective.2
Little is known about the outcomes or the number of
TJRs performed in SSA. The age of patients and their
indications for TJR diﬀer considerably from those in
the developed world and include a larger proportion of
patients living with HIV.3,4 Facilities, resources and
training of surgeons and allied health professionals
are substantially diﬀerent from those of a high-
income country.5 It cannot be assumed that outcomes
as seen on TJR registries, such as the UK National
Joint Registry, will directly transpose to SSA.4
The cost of TJR is signiﬁcant; costs in the USA are
in the range of US$16,000–60,000 for the procedure
alone, depending on the institution.6 In the UK
National Health Service, where prices are dictated
more by true cost than proﬁt, total knee replacements
(TKR) and total hip replacements (THR) are thought
to cost approximately US$7000–9000 per procedure.7
There are currently no systematic reviews in the lit-
erature investigating the outcomes of TJR in SSA. This
review explores the literature surrounding outcomes of
THR and TKR in SSA, including patient-reported out-
come measures, evidence of complications, length of
inpatient stay, inpatient mortality and revision rates.
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Methods
Scopus, EMBASE, Medline and PubMed databases
were searched including papers published at any date
up to and including 2018. Eligibility criteria are listed in
Table 1. Papers from South Africa were excluded owing
to the fact that the provision of healthcare and research
resources are diﬀerent to the majority of SSA.8 South
Africa is the second largest economy in SSA and
although around 40% of the population live below
the poverty line of ZAR 416 (about US$35 per
month), a large proportion of the population have
access to private healthcare in line with that provided
by Europe and North America.9 This makes compari-
sons of the results of arthroplasty outcomes with the
rest of SSA diﬃcult.
Medical subject headings (MeSH) were combined
using a Boolean strategy, using synonyms, alternate
spellings and abbreviations, and are listed in Table 2.
Eligible studies were backwards referenced to improve
the search. Where papers were identiﬁed to duplicate
reporting of earlier work, they were included with
explanations provided.5,10–12 The ﬁnal search was
undertaken on 4 November 2018. The preferred report-
ing items for systematic reviews and meta-analyses
(PRISMA) process was followed (Figure 1).
Results
Twelve papers were included and the results are dis-
played in Table 3.5,10–20 Outcomes from 606 THRs
and 763 TKRs were reported from seven countries
between 2009 and 2018. Three papers included results
for both THR and TKR; for two of these, the results
could be broken down into those for the two diﬀerent
procedures10,11 but there was insuﬃcient information in
the third paper to do this.19 Seven studies were per-
formed using a prospectively collected database for
data collection.5,10,12–14,16,17,20 The remainder of studies
were performed retrospectively.
Patient demographics
The median number of patients included in each paper
was 58 (range¼ 8–313 patients). Patient demographics
are included in Table 3 for each paper individually.
Surgical methods
Researchers reported in varying detail about their sur-
gical protocols. Laminar airﬂow was not used in any
surgical centre, but DVT prophylaxis and perioperative
antibiotics were used without exception. Patients were
generally encouraged to mobilise full weight-bearing
from day 1 or 2 postoperatively, except in one study
where patients underwent bed-rest for one week.19
Details of implant types and cementing techniques are
given in Table 4.
HIV-positive patients
Graham et al. reported on a cohort of patients with
HIV undergoing THR, with excellent results. No com-
plications were seen at a mean follow-up of 42
months.12 A second paper by Graham et al. reported
no complications in the nine HIV-positive patients
undergoing TKR.13 Data on HIV status were otherwise
poorly reported. Lisenda et al. excluded all HIV-posi-
tive patients;11 Lubega et al. tested 42 of 58 patients
undergoing THR and found one-third were HIV-posi-
tive; and Mulla et al. tested only 12% of patients and
found a similar prevalence.5,19 No further papers
reported on HIV status and no studies were designed
to compare outcomes of patients living with HIV to
healthy controls.
Table 1. Inclusion and exclusion criteria.
Type of criteria Description Rationale
Inclusion Short- or long-term outcomes of total knee or hip TJR As per research question
Performed in SSA As per research question
Studies produced in last 20 years To maximise inclusion
Exclusion Studies performed in South Africa Outlier in terms of development
Study not available in English To minimise error
Table 2. MeSH headings.
Group 1 (OR) AND Group 2 (OR)
Total knee Africa
TKR Sub-Saharan
TJR Poor country
Knee replacement Developing country
Hip replacement
THR
Total hip
2 Tropical Doctor 0(0)
Outcomes
Detailed outcomes are displayed in Table 3. Length of
inpatient stay was reported in six papers and mean
values were in the range of 7–14 days.5,10,13,14,16,20
No information was provided in other papers.
Inpatient mortality was well reported, with only one
paper not speciﬁcally stating a value.15 The overall
rate in TKR was 0.9%,10,11,13,14,16,20 while in THR it
was 0.2%.5,10–12,17,18
Patients were followed up for various times
(mean¼ 18 months; range¼ 0–149 months).10,12–16
Incomplete data regarding follow-up were provided in
four papers.11,17,19,20 No data were provided in two
papers.5,18
Six papers reported pre- and postoperative patient-
reported outcome measures. Knee Society Scores (KSS)
(range¼ 0–100) were shown to improve from 21.35
(range¼ 0–51) to 88 (range¼ 60–100);14 Oxford Knee
Scores (OKS) (range¼ 0–48 or 12–60) were quoted to
improve from 15.5 (range¼ 4–24) to 44.5 (range¼
35–59), 16.8 (range¼ 4–36) to 45.6 (range¼ 29–48)
and from 12 to 45.5 (no ranges given).13,16,20 Harris
Hip Scores (HHS) (range¼ 0–100) improved from 29
(range¼ 9–50) to 85 (range¼ 79–91)and from 27
(range¼ 6–56) to 86 (range¼ 73–91) in two separate
studies.5,12 All papers described complications and all
but three provided details of revision rates.10,14,19 The
mean deep infection rate for TKRs was 1.6% from all
studies,11,13–16,20 while for THRs it was 0.5% from all
studies.5,11,12,17–19 The dislocation rate for THRs was
1.6%.5,11,12,17–19 Details of head sizes and approaches
used are given in Table 5.
Discussion
To the authors’ knowledge, this is the ﬁrst systematic
review of TJR in SSA and there are many diﬀerences
between the environment, patient cohort and health-
care provisions when performing TJR in SSA, com-
pared to high-income countries.
Model of healthcare in sub-Saharan Africa
Healthcare may be provided ‘free at the point of use’
and funded through taxation or through health insur-
ance or self-payment.21 Most high-income countries
have a coexisting healthcare model where healthcare
PubMed = 191 SCOPUS = 215 EMBASE = 196 Medline = 70 
Total = 672 
Relevant = 19 
Screened abstracts 
manually 
Inclusion = 12 
Backwards 
Referencing = +3 
Google Scholar = +1 
Removed Duplicates= 9 
Main Text in English Language = -1 
Figure 1. PRISMA diagram.
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Table 4. Details of implants and cementing techniques used.
Author (date) Implant details Cementing details
TKR
Katchy et al.20 (2018) 68 DePuy Biomet PS No data
Graham et al.13 (2018) 171 DePuy CR PFC
2 DePuy CS PFC
4 Biomet AGC
All Smartset GHV
Anyaehie et al.14 (2017) All Johnson and Johnson PFC Sigma All Palacos
Lisenda et al.10 (2016) No data 145 cemented
42 hybrid
6 uncemented
Lisenda et al.11 (2016) Smith and Nephew Profix 26 cemented
26 hybrid
6 uncemented
Kigera and Kimpiatu15 (2015) 81 DePuy
12 Zimmer
All cemented
2 g Gentamicin in 40 g cement
George and Ofori-Atta16 (2009) No Data No data
THR
Lisenda et al.10 (2016) No data 147 uncemented
6 hybrid
Lisenda et al.11 (2016) 41 Smith and Nephew porous synergy
1 Spectron Hip
15 Reflection Spiked Acetabulum
27 R3 Acetabulum
All uncemented
Dossche et al.17 (2014) 141 Charnley or Kheos
3 Vives Femur
All femurs cemented
5 uncemented acetabulum
147 cemented acetabulum
Graham et al.12 (2014) 45 Charnley and Ogee
3 Biomet Stanmore
All Smartset GHV
Kingori and Gakuu18 (2010) No data All cemented
Lubega et al.5 (2009) 43 Charnley and Ogee
29 Biomet Stanmore
All Smartset GHV
Combined
Mulla et al.19 (2010) No data No data
Table 5. Head sizes and approaches used in THRs.
Author (date)
Dislocation
rate (%)
Mean follow-up
(months) (range) Head sizes (mm)
Head size
(dislocated) (mm)
Approaches
used (%)
THR
Lisenda et al.10 (2016) 0 0 No data N/A Anterolateral 100
Lisenda et al.11 (2016) 2.4 No mean (26–47) 36 (57.1%)
32 (4.8%)
28 (38.1%)
28 (100%) Anterolateral 100
Dossche et al.17 (2014) 1.3 Min 6–8 No data No data Anterolateral 100
Graham et al.12 (2014) 0 42 (6–98) Insufficient data N/A No data
Kingori and Gakuu18 (2010) 1 No data No data No data Anterolateral 95
Posterior 5
Lubega et al.5 (2009) 1.4 No data Insufficient data No data No data
Combined
Mulla et al.19 (2010) 7 Min 1 28 (51.6%)
Missing data in 48.4%
No data Hardinge 84.3
6 Tropical Doctor 0(0)
insurance is available to those who can aﬀord it, with a
state-run safety net for those who cannot. Examples of
both types of healthcare are found in SSA, but each
comes with its own limitations in these populations.
Nigeria, for example, has historically had no healthcare
insurer.14 Diﬀerent countries within SSA have hugely
variable economic circumstances, as demonstrated in
Table 3.22 The gross national income per capita is
US$16,710 in Botswana but only US$320 in Malawi.22
Average government spending on healthcare across SSA
has been reported as US$90 (range¼ US$14–663) per
year per person, which compares to a typical value of
>US$5200 in high-income countries.23,24
Several institutes in SSA work in collaboration with
experienced high-volume TJR surgeons from high-
income countries, who visit them temporarily to per-
form surgery.10,11,17 This has the beneﬁt of training
locally based surgeons to become independent arthro-
plasty surgeons in areas where this training is otherwise
not available. However, one of the main drawbacks of
using visiting surgeons is continuity of care and that
these surgeons are unlikely to be available to follow
up the patient if they develop a complication requiring
further surgery.
From our experience, we believe the best provision
of any arthroplasty service is by a local multidisciplin-
ary arthroplasty team. This team can beneﬁt from input
from international support if the appropriate training
and experience is not initially established but should
aim to become self-governing. An example of this
approach is the Malawi National Joint Registry.5,12,13
Differences in patient demographics in sub-Saharan
Africa
In SSA, the adult prevalence of HIV in 2013 was
approximately 4.7%, compared with 0.3% in Europe
and North America.3 Within SSA, prevalence estimates
also vary between countries; for example, in 2013 the
estimates for Malawi and Botswana were 21.9%
and 10.3%, respectively.3 Only ﬁve of our papers
documented HIV status.5,11–13,19 Graham et al. demon-
strated no increased risk of complications in HIV-
positive patients undergoing THR, including infection.12
However, no other papers reported outcomes related to
HIV-positive patients undergoing TJR.
In patients from SSA, avascular necrosis was a fre-
quent indication for THR and has previously been
associated with HIV infection.25 Lubega et al. found
49% of patients in their study had avascular necrosis
and, of these, 44% had HIV.5 Mulla et al. did not ﬁnd
such a high rate of avascular necrosis (14%) but
acknowledged they did not have magnetic resonance
imaging facilities and may have attributed painful
hips to osteoarthritis without further consideration.19
Patients were younger than those seen with osteoarth-
ritis in high-income countries, which may indicate an
increased prevalence of avascular necrosis than that
which was reported. Mulla et al. found a higher rate
of dislocation at 3.9% and suggested several cultural
reasons.19 Patients often use squat toilets and kneel
for prayer, requiring deep hip ﬂexion, which contradicts
routine THR precautions. Patients may also be manual
workers, e.g. farmers, and need to work as soon as
possible after their surgery, owing to minimal social
support. Patients’ occupations were not reported in
any study, so conclusions may not be drawn.
Outcomes of surgery in sub-Saharan Africa
Use of laminar ﬂow is rare in SSA but has been stand-
ard for TJR in high-income countries since it was intro-
duced by Sir John Charnley in the 1970s.26 However, its
necessity has recently been questioned.27 An underlying
diagnosis of avascular necrosis has previously been
linked to increased risk of infection, 90-day mortality,
readmission and revision, in some studies.28,29 Overall
infection rates in SSA appeared satisfactory, as demon-
strated in Table 3.
The observed improvement in mean OKS was a
greater increase than typically seen in high-income
countries.16 The 2013 report of the UK National
Joint Registry presented an average increase from 19
to 26.30 An improvement in mean KSS was reported
and data from a high-income county have shown smal-
ler improvements in KSS from 53 to 80.14,31 Allowing
for some natural decline in function with 3–6 years of
extra follow-up in the high-income group, these data
are still likely to represent a similar if not superior
improvement in function in the SSA paper.14
Improvements in HHS from 29 to 85 were noted.5
This compares with data from a high-income country,
showing improvement from 43 to 87.32 Again, inferior
preoperative scores were noted in SSA, indicating that
patients are more likely to have advanced disease and
may stand to beneﬁt more from TJR than patients in
high-income countries, who are likely to present earlier
for treatment.
Joint registries in sub-Saharan Africa
Malawi is the only country in SSA to have a dedicated
national joint registry.5,12,13 The majority of the data
from SSA was collected using local prospective data-
bases.10,11,14,16,17,19 Reported study size varied but was
generally small. This compares with the most recent
report on the UK National Joint Registry, which
included 2.35 million records.4 The ﬁrst country to
develop a national orthopaedic registry to determine
outcomes of TJR was Sweden in 1975.33 Since then,
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many high-income countries have developed similar
programmes. The beneﬁts of national registries are
many and include eliminating reporting bias, allowing
comparison between units, and early identiﬁcation of
problem implants and techniques.
Follow-up
There are several limitations to the follow-up process in
SSA. Patients may have to travel large distances to
attend follow-up, with signiﬁcant time or cost invest-
ment to do so. In a study from Kenya, Kingori and
Gakuu found 34% loss to follow-up at six months.18
However, with investment in a dedicated TJR follow-
up clinic and dedicated nurse, as well as provision of
outreach clinics, Lisenda et al. were able to maintain
100% follow-up.11 Improvement in follow-up is likely
with increasing access to mobile phones and reminders
through this method have been shown to work well in
antiretroviral therapy programmes.34
Limitations
There is likely to be a profound reporting bias in studies
from SSA with only those centres with good results pub-
lishing their outcomes. Centres with poor results would
probably choose not to do so. The only way to avoid this
is to introduce mandatory national registries that would
eliminate this bias. This would also increase the number
of patients reported on and thus give more reliable data.
Two papers duplicated follow-up of earlier
papers.10,12 Graham et al. reported from the same data-
base as the previous Lubega et al. paper but speciﬁcally
looked only at patients with HIV and therefore it was
useful to include this paper.5,12 Lisenda et al. published
two papers, one of which looked only at the inpatient
period of care.10,11 This included a larger cohort of
patients but is likely to have duplicated some reporting.
It was impossible to identify the signiﬁcance of this
from the manuscripts.
The overall outcomes of TJR surgery in SSA are posi-
tive; however, it must be noted that the patient popula-
tion reported on, of predominantly self-paying patients,
is likely to be healthy, well-nourished and well supported
socially. Surgery is also likely to be performed in private
well-funded hospitals. The included studies are not likely
to represent results of the general population undergoing
surgery in government hospitals. If it were ﬁnancially
possible to extend TJR across all population groups, it
may be found that complication rates and outcomes
vary. Implementation of mandatory national registries
would ensure transparency of outcomes and allow
appropriate targeting of resources and training.
This research only included studies that were pub-
lished in the English language and as a result, relevant
studies published in other languages are likely to have
been missed.
Conclusions
Overall, positive results were reported from TJRs in
SSA, with comparable rates of complications to those
reported in high-income countries. However, there is
likely to be signiﬁcant reporting bias, and the introduc-
tion of national and regional joint registries would have
the beneﬁt of allowing more accurate monitoring of
outcomes.
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